Therapeutic peptides are emerging as promising drug candidates, garnering significant attention in the field of medicine and drug development due to their high specificity, affinity, and low toxicity [1-3]
1,2 These findings represent the first and only phase 3 clinical trial data with an investigational long-acting amylin analogue monotherapy for the management of obesity
Individual results vary significantly based on injury type, severity, duration, product quality, and personal healing capacity
Approximately 70% of women with these conditions have a BMI of 30 or higher and often carry metabolic diagnoses such as PCOS or type 2 diabetes
Muscle and growth signaling PEG-MGF (Pegylated Mechano Growth Factor) A modified form of mechano growth factor, studied for muscle repair and recovery